Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 369 |
|
|||||
| News | (1) |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Scilex Holding Company | SCLXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0198 | 22.00% | 0.1098 | 15:14:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.10 | 0.10 | 0.1098 | 0.1098 | 0.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 13 | 369 | 0.1097999 | 41 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 1 | 0.10 | USD |
Scilex Holding Company Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 14.03M | 155.94M | - | 46.74M | -114.33M | -0.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Scilex
| Date | Time | Source | Heading |
|---|---|---|---|
| 2/26/2025 | 15:06 | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials |
| 2/14/2025 | 15:01 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 1/23/2025 | 20:21 | Edgar (US Regulatory) | Form SCHEDULE 13D/A - General Statement of Acquisition of.. |
| 1/23/2025 | 18:49 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/22/2025 | 05:17 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/22/2025 | 05:15 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/22/2025 | 05:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/21/2025 | 16:18 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/21/2025 | 16:16 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/21/2025 | 15:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/17/2025 | 19:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/17/2025 | 15:57 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
SCLXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5. |
NASDAQ:SCLXW -
What is the current Scilex Holding Company share price?
The current share price of Scilex Holding Company is US$ 0.1098
How many Scilex Holding Company shares are in issue?
Scilex Holding Company has 155,943,000 shares in issue
What is the market cap of Scilex Holding Company?
The market capitalisation of Scilex Holding Company is USD 14.03M
What is the 1 year trading range for Scilex Holding Company share price?
Scilex Holding Company has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Scilex Holding Company?
The price to earnings ratio of Scilex Holding Company is -0.37
What is the cash to sales ratio of Scilex Holding Company?
The cash to sales ratio of Scilex Holding Company is 0.9
What is the reporting currency for Scilex Holding Company?
Scilex Holding Company reports financial results in USD
What is the latest annual turnover for Scilex Holding Company?
The latest annual turnover of Scilex Holding Company is USD 46.74M
What is the latest annual profit for Scilex Holding Company?
The latest annual profit of Scilex Holding Company is USD -114.33M
What is the registered address of Scilex Holding Company?
The registered address for Scilex Holding Company is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Scilex Holding Company website address?
The website address for Scilex Holding Company is www.scilexholding.com
Which industry sector does Scilex Holding Company operate in?
Scilex Holding Company operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
